2297 Stock Overview
Operates as a vascular interventional surgical robotics company in China and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rainmed Medical Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.15 |
52 Week High | HK$0.92 |
52 Week Low | HK$0.14 |
Beta | 1.28 |
11 Month Change | -10.12% |
3 Month Change | -45.09% |
1 Year Change | -83.22% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -97.14% |
Recent News & Updates
Recent updates
Shareholder Returns
2297 | HK Medical Equipment | HK Market | |
---|---|---|---|
7D | -6.2% | 0.9% | -0.1% |
1Y | -83.2% | -45.6% | -3.2% |
Return vs Industry: 2297 underperformed the Hong Kong Medical Equipment industry which returned -45.6% over the past year.
Return vs Market: 2297 underperformed the Hong Kong Market which returned -3.2% over the past year.
Price Volatility
2297 volatility | |
---|---|
2297 Average Weekly Movement | 13.4% |
Medical Equipment Industry Average Movement | 6.8% |
Market Average Movement | 6.5% |
10% most volatile stocks in HK Market | 13.5% |
10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 2297's share price has been volatile over the past 3 months.
Volatility Over Time: 2297's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 406 | Yunfei Huo | rainmed.com |
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coronary artery ischemia severity based on coronary angiography images; and caIMR System, including FlashAngio caIMR System and FlashPressure caIMR pressure transducer, which is a less-invasive index of microcirculatory resistance measurement product for the treatment of microcirculatory lesions.
Rainmed Medical Limited Fundamentals Summary
2297 fundamental statistics | |
---|---|
Market cap | HK$176.34m |
Earnings (TTM) | -HK$125.77m |
Revenue (TTM) | HK$79.50m |
2.2x
P/S Ratio-1.4x
P/E RatioIs 2297 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2297 income statement (TTM) | |
---|---|
Revenue | CN¥73.22m |
Cost of Revenue | CN¥24.67m |
Gross Profit | CN¥48.55m |
Other Expenses | CN¥164.38m |
Earnings | -CN¥115.83m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.099 |
Gross Margin | 66.31% |
Net Profit Margin | -158.20% |
Debt/Equity Ratio | 3.0% |
How did 2297 perform over the long term?
See historical performance and comparison